Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy
Light Therapy to Prevent Frailty in Older Men With Prostate Cancer on Hormonal Therapy: A Pilot RCT
Sponsor: City of Hope Medical Center
This EARLY_PHASE1 trial investigates Prostate Carcinoma and is currently completed. City of Hope Medical Center leads this study, which shows 16 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
16 versions recorded-
May 2025 — Present [monthly]
Completed EARLY_PHASE1
Status: Active Not Recruiting → Completed
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Sep 2024 — Apr 2025 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
▶ Show 11 earlier versions
-
Jun 2023 — May 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jun 2022 — Jun 2023 [monthly]
Active Not Recruiting EARLY_PHASE1
Phase: NA → EARLY_PHASE1
-
Oct 2021 — Jun 2022 [monthly]
Active Not Recruiting NA
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2020 — Apr 2020 [monthly]
Recruiting NA
-
Oct 2019 — Feb 2020 [monthly]
Recruiting NA
-
Jul 2019 — Oct 2019 [monthly]
Recruiting NA
-
Nov 2018 — Jul 2019 [monthly]
Recruiting NA
-
Oct 2018 — Nov 2018 [monthly]
Recruiting NA
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- City of Hope Medical Center
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .